Buyun Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Buyun Ma has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Can Yue
Sichuan Univ, West China Hosp, Dept Med Ultrasound, 37 Guoxue Alley, Chengdu 610041, Peoples R China
2 shared publications- Juanmei Chen
Department of Ultrasound, West China Hospital, Sichuan University, Chengdu 610041, China
2 shared publications Wanting Yang
Sichuan Univ, West China Hosp, Dept Med Ultrasound, 37 Guoxue Alley, Chengdu 610041, Peoples R China
2 shared publications- Ayibota Ruxian
Department of Ultrasound, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication Beibei Ye
Tongji Univ, Shanghai Peoples Hosp 10,Dept Med Ultrasound, Shanghai Engn Res Ctr Ultrasound Diag & Treatment, Sch Med,Ultrasound Res & Educ Inst,Canc Ctr, Shanghai 200072, Peoples R China
1 shared publicationBingjie Zhang
Nanjing Med Univ, Dept Med Ultrasound, Affiliated Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 11 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8829
A Rare Case of Painful Thyroiditis: Initially Suspected as Subacute Thyroiditis, Ultimately Diagnosed as Hashimoto Thyroiditis
Background: Painful Hashimoto thyroiditis (pHT) is a rare variant of Hashimoto thyroiditis (HT). Because neck pain, raised inflammatory markers and an initial response to glucocorticoids are shared with subacute thyroiditis (SAT), pHT is frequently misdiagnosed. We describe a steroid-dependent case to highlight the features that help distinguish pHT from SAT. Methods: A 49-year-old Chinese woman with a 10-year history of goiter and treated hypothyroidism presented with recurrent painful neck swelling initially diagnosed as SAT. Evaluation comprised thyroid function, autoantibodies, inflammatory markers, grayscale, Doppler and contrast-enhanced ultrasound, ultrasound-guided 18-gauge core-needle biopsy, and, after thyroidectomy, histopathology, immunohistochemistry and immunoglobulin gene rearrangement analysis. Results: The erythrocyte sedimentation rate was markedly elevated, thyroid autoantibodies were modestly positive, and no thyrotoxic phase was documented. Pain relapsed during each of two prednisone tapers, despite the addition of mycophenolate mofetil to the second. Biopsy and surgical histology showed HT, with no evidence of malignancy, IgG4-related disease or B-cell clonality. Total thyroidectomy resolved the pain, and the patient remained pain-free on levothyroxine at 24-month follow-up. Conclusions: Recurrent “SAT” in a patient with pre-existing autoimmune thyroid disease, especially when pain relapses with each steroid taper, should prompt tissue diagnosis; total thyroidectomy provides durable relief in refractory pHT.
- 11 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 8829
Open AccessA Rare Case of Painful Thyroiditis: Initially Suspected as Subacute Thyroiditis, Ultimately Diagnosed as Hashimoto Thyroiditis
Background: Painful Hashimoto thyroiditis (pHT) is a rare variant of Hashimoto thyroiditis (HT). Because neck pain, raised inflammatory markers and an initial response to glucocorticoids are shared with subacute thyroiditis (SAT), pHT is frequently misdiagnosed. We describe a steroid-dependent case to highlight the features that help distinguish pHT from SAT. Methods: A 49-year-old Chinese woman with a 10-year history of goiter and treated hypothyroidism presented with recurrent painful neck swelling initially diagnosed as SAT. Evaluation comprised thyroid function, autoantibodies, inflammatory markers, grayscale, Doppler and contrast-enhanced ultrasound, ultrasound-guided 18-gauge core-needle biopsy, and, after thyroidectomy, histopathology, immunohistochemistry and immunoglobulin gene rearrangement analysis. Results: The erythrocyte sedimentation rate was markedly elevated, thyroid autoantibodies were modestly positive, and no thyrotoxic phase was documented. Pain relapsed during each of two prednisone tapers, despite the addition of mycophenolate mofetil to the second. Biopsy and surgical histology showed HT, with no evidence of malignancy, IgG4-related disease or B-cell clonality. Total thyroidectomy resolved the pain, and the patient remained pain-free on levothyroxine at 24-month follow-up. Conclusions: Recurrent “SAT” in a patient with pre-existing autoimmune thyroid disease, especially when pain relapses with each steroid taper, should prompt tissue diagnosis; total thyroidectomy provides durable relief in refractory pHT.
- Open Access
- 16 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6330
Erdheim–Chester Disease with Breast and Axillary Involvement Diagnosed by Ultrasound-Guided Biopsy: A Case Report and Literature Review
Background/Objectives: Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by multisystem infiltration of foamy histiocytes, leading to chronic inflammation, fibrosis, and organ dysfunction. Breast involvement in ECD is extremely uncommon, and the sonographic features of ECD involving the breast remain poorly described. Case Presentation: We report the case of a 59-year-old woman with chronic bone pain and multisystem disease who experienced an extended diagnostic course despite undergoing renal biopsy, biopsy of a right elbow lesion, bone marrow examination, and multidisciplinary evaluation. Breast ultrasound revealed bilateral infiltrative hypoechoic lesions involving the breasts and axillae. These were classified as BI-RADS 4C and were highly suspicious for breast malignancy. Subsequently, an ultrasound-guided core needle biopsy was performed on the breast and axillary lesions. Results: Histopathology showed fibroadipose tissue infiltrated by numerous foamy histiocytes, scattered epithelioid cells, and occasional Touton giant cells. Immunohistochemistry showed positivity for CD68, CD163, CD4, and Cyclin D1, partial positivity for OCT2 and CD30, and negativity for S100, CD1a, Langerin, ALK, CK (Pan), and GATA3. The Ki-67 index was approximately 3%. Molecular testing detected the BRAF V600E mutation, supporting the diagnosis of ECD. A review of reported cases showed that breast involvement in ECD lacks specific ultrasound findings and may closely mimic primary breast malignancy. Conclusions: Breast involvement in ECD is rare and may present as bilateral infiltrative hypoechoic lesions with axillary involvement on ultrasound. In patients with chronic bone pain, symmetric osteosclerosis, or multisystem disease, ECD should be considered in the differential diagnosis. Ultrasound-detected superficial lesions may provide accessible biopsy targets, helping to establish a timely diagnosis and reduce diagnostic delay.
- 16 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (16) , 6330
Open AccessErdheim–Chester Disease with Breast and Axillary Involvement Diagnosed by Ultrasound-Guided Biopsy: A Case Report and Literature Review
Background/Objectives: Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis characterized by multisystem infiltration of foamy histiocytes, leading to chronic inflammation, fibrosis, and organ dysfunction. Breast involvement in ECD is extremely uncommon, and the sonographic features of ECD involving the breast remain poorly described. Case Presentation: We report the case of a 59-year-old woman with chronic bone pain and multisystem disease who experienced an extended diagnostic course despite undergoing renal biopsy, biopsy of a right elbow lesion, bone marrow examination, and multidisciplinary evaluation. Breast ultrasound revealed bilateral infiltrative hypoechoic lesions involving the breasts and axillae. These were classified as BI-RADS 4C and were highly suspicious for breast malignancy. Subsequently, an ultrasound-guided core needle biopsy was performed on the breast and axillary lesions. Results: Histopathology showed fibroadipose tissue infiltrated by numerous foamy histiocytes, scattered epithelioid cells, and occasional Touton giant cells. Immunohistochemistry showed positivity for CD68, CD163, CD4, and Cyclin D1, partial positivity for OCT2 and CD30, and negativity for S100, CD1a, Langerin, ALK, CK (Pan), and GATA3. The Ki-67 index was approximately 3%. Molecular testing detected the BRAF V600E mutation, supporting the diagnosis of ECD. A review of reported cases showed that breast involvement in ECD lacks specific ultrasound findings and may closely mimic primary breast malignancy. Conclusions: Breast involvement in ECD is rare and may present as bilateral infiltrative hypoechoic lesions with axillary involvement on ultrasound. In patients with chronic bone pain, symmetric osteosclerosis, or multisystem disease, ECD should be considered in the differential diagnosis. Ultrasound-detected superficial lesions may provide accessible biopsy targets, helping to establish a timely diagnosis and reduce diagnostic delay.
- Open Access
- 19 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (12) , 1909
Deep Learning Based on B-Mode and Color Doppler Ultrasound for Differentiation of Primary Thyroid Lymphoma and Hashimoto’s Thyroiditis: A Retrospective Single-Center Study
Background/Objectives: Primary thyroid lymphoma (PTL), including diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma, share substantial overlap in ultrasound appearance with Hashimoto’s thyroiditis (HT), making preoperative differentiation challenging. This study aims to develop and validate a deep learning model based on B-mode ultrasound (BMUS) and color Doppler ultrasound (CDUS) for image-level differentiation of DLBCL, MALT lymphoma, and HT. Methods: This retrospective single-center study included 1294 ultrasound images from 290 patients (313 lesions) who underwent preoperative ultrasound examination at West China Hospital between September 2002 and September 2024. All images from the same lesion were assigned to the same data partition, and the dataset was split at the lesion level into training and test sets at an 8:2 ratio. A Frequency-Adaptive WT-ResNet model incorporating wavelet transform convolution and a frequency-adaptive gating mechanism was developed. The primary analysis was performed at the image level. The performance of the model was compared with that of three ultrasound physicians with different levels of experience. Grad-CAM was used for visual interpretation. An exploratory external validation was performed using an independent dataset from Sun Yat-sen Memorial Hospital. Results: In the test set, the model achieved a macro-average AUC of 0.927 (95% CI: 0.889–0.960), with class-specific AUCs of 0.899 for DLBCL, 0.946 for MALT lymphoma, and 0.937 for HT. The macro-average balanced accuracy was 0.866, compared with 0.827 for that of the best-performing senior physician. The exploratory validation set yielded a macro-average AUC of 0.796 (95% CI: 0.686–0.888), with class-specific AUCs of 0.806 for DLBCL, 0.825 for HT, and 0.756 for MALT lymphoma. Grad-CAM showed that the model focused on lesion-internal echotexture and lesion-transition regions with class-dependent patterns. Conclusions: A deep learning model based on BMUS and CDUS showed promising performance for image-level differentiation of DLBCL, MALT lymphoma and HT in a single-center retrospective cohort. The model outperformed three ultrasound physicians and may serve as a potential decision-support tool. However, the exploratory external validation results should be interpreted as preliminary, and larger multicenter cohorts remain necessary to confirm model generalizability.
- 19 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (12) , 1909
Open AccessDeep Learning Based on B-Mode and Color Doppler Ultrasound for Differentiation of Primary Thyroid Lymphoma and Hashimoto’s Thyroiditis: A Retrospective Single-Center Study
Background/Objectives: Primary thyroid lymphoma (PTL), including diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma, share substantial overlap in ultrasound appearance with Hashimoto’s thyroiditis (HT), making preoperative differentiation challenging. This study aims to develop and validate a deep learning model based on B-mode ultrasound (BMUS) and color Doppler ultrasound (CDUS) for image-level differentiation of DLBCL, MALT lymphoma, and HT. Methods: This retrospective single-center study included 1294 ultrasound images from 290 patients (313 lesions) who underwent preoperative ultrasound examination at West China Hospital between September 2002 and September 2024. All images from the same lesion were assigned to the same data partition, and the dataset was split at the lesion level into training and test sets at an 8:2 ratio. A Frequency-Adaptive WT-ResNet model incorporating wavelet transform convolution and a frequency-adaptive gating mechanism was developed. The primary analysis was performed at the image level. The performance of the model was compared with that of three ultrasound physicians with different levels of experience. Grad-CAM was used for visual interpretation. An exploratory external validation was performed using an independent dataset from Sun Yat-sen Memorial Hospital. Results: In the test set, the model achieved a macro-average AUC of 0.927 (95% CI: 0.889–0.960), with class-specific AUCs of 0.899 for DLBCL, 0.946 for MALT lymphoma, and 0.937 for HT. The macro-average balanced accuracy was 0.866, compared with 0.827 for that of the best-performing senior physician. The exploratory validation set yielded a macro-average AUC of 0.796 (95% CI: 0.686–0.888), with class-specific AUCs of 0.806 for DLBCL, 0.825 for HT, and 0.756 for MALT lymphoma. Grad-CAM showed that the model focused on lesion-internal echotexture and lesion-transition regions with class-dependent patterns. Conclusions: A deep learning model based on BMUS and CDUS showed promising performance for image-level differentiation of DLBCL, MALT lymphoma and HT in a single-center retrospective cohort. The model outperformed three ultrasound physicians and may serve as a potential decision-support tool. However, the exploratory external validation results should be interpreted as preliminary, and larger multicenter cohorts remain necessary to confirm model generalizability.
- Open Access
- 3 January 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (1) , 29
Application of Ultrasound Radiomics in Differentiating Benign from Malignant Breast Nodules in Women with Post-Silicone Breast Augmentation
Purpose: To evaluate the diagnostic value of ultrasound radiomics in distinguishing between benign and malignant breast nodules in women who have undergone silicone breast augmentation. Methods: A retrospective study was conducted of 99 breast nodules detected by ultrasound in 93 women who had undergone silicone breast augmentation. The ultrasound data were collected between 1 January 2006 and 1 September 2023. The nodules were allocated into a training set (n = 69) and a validation set (n = 30). Regions of interest (ROIs) were manually delineated using 3D Slicer software, and radiomic features were extracted and selected using Python programming. Eight machine learning algorithms were applied to build predictive models, and their performance was assessed using sensitivity, specificity, area under the ROC curve (AUC), accuracy, Brier score, and log loss. Model performance was further evaluated using ROC curves and calibration curves, while clinical utility was assessed via decision curve analysis (DCA). Results: The random forest model exhibited superior performance in differentiating benign from malignant nodules in the validation set, achieving sensitivity of 0.765, specificity of 0.838, and an AUC of 0.787 (95% CI: 0.561–0.960). The model’s accuracy, Brier score, and log loss were 0.796, 0.197, and 0.599, respectively. DCA suggested potential clinical utility of the model. Conclusion: Ultrasound radiomics demonstrates promising diagnostic accuracy in differentiating benign from malignant breast nodules in women with silicone breast prostheses. This approach has the potential to serve as an additional diagnostic tool for patients following silicone breast augmentation.
- 3 January 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (1) , 29
Open AccessApplication of Ultrasound Radiomics in Differentiating Benign from Malignant Breast Nodules in Women with Post-Silicone Breast Augmentation
Purpose: To evaluate the diagnostic value of ultrasound radiomics in distinguishing between benign and malignant breast nodules in women who have undergone silicone breast augmentation. Methods: A retrospective study was conducted of 99 breast nodules detected by ultrasound in 93 women who had undergone silicone breast augmentation. The ultrasound data were collected between 1 January 2006 and 1 September 2023. The nodules were allocated into a training set (n = 69) and a validation set (n = 30). Regions of interest (ROIs) were manually delineated using 3D Slicer software, and radiomic features were extracted and selected using Python programming. Eight machine learning algorithms were applied to build predictive models, and their performance was assessed using sensitivity, specificity, area under the ROC curve (AUC), accuracy, Brier score, and log loss. Model performance was further evaluated using ROC curves and calibration curves, while clinical utility was assessed via decision curve analysis (DCA). Results: The random forest model exhibited superior performance in differentiating benign from malignant nodules in the validation set, achieving sensitivity of 0.765, specificity of 0.838, and an AUC of 0.787 (95% CI: 0.561–0.960). The model’s accuracy, Brier score, and log loss were 0.796, 0.197, and 0.599, respectively. DCA suggested potential clinical utility of the model. Conclusion: Ultrasound radiomics demonstrates promising diagnostic accuracy in differentiating benign from malignant breast nodules in women with silicone breast prostheses. This approach has the potential to serve as an additional diagnostic tool for patients following silicone breast augmentation.
- Open Access
- 1 April 2024
- Published by AME Publishing Company in Chinese Clinical Oncology
- Vol. 13 (2) , 21
Stepwise analysis of thyroid diagnostic modalities with genomic imprinting detection
Background: The current preoperative malignancy risk evaluation for thyroid nodules involves stepwise diagnostic modalities including ultrasonography, thyroid function serology and fine-needle aspiration (FNA) cytopathology, respectively. We aimed to substantiate the stepwise contributions of each diagnostic step and additionally investigate the diagnostic significance of quantitative chromogenic imprinted gene in-situ hybridization (QCIGISH)—an adjunctive molecular test based on epigenetic imprinting alterations. Methods: A total of 114 cytopathologically-diagnosed and histopathologically-confirmed thyroid nodules with complete ultrasonographic and serological examination records were evaluated using QCIGISH in the study. Logistic regression models for thyroid malignancy prediction were developed with the stepwise addition of each diagnostic modality and the contribution of each step evaluated in terms of discrimination performance and goodness-of-fit. Results: From the baseline model using ultrasonography [area under the receiver operating characteristics curve (AUROC): 0.79; 95% confidence interval (CI): 0.71–0.86], significant improvements in thyroid malignancy discrimination were observed with the stepwise addition of thyroid function serology (AUROC: 0.82; 95% CI: 0.74–0.90; P=0.23) and FNA cytopathology (AUROC: 0.88; 95% CI: 0.81–0.94; P=0.02), respectively. The inclusion of QCIGISH as an adjunctive molecular test further advanced the preceding model’s diagnostic performance (AUROC: 0.95; 95% CI: 0.91–1.00, P=0.007). Conclusions: Our study demonstrated the significant stepwise diagnostic contributions of standard clinical assessments in the malignancy risk stratification of thyroid nodules. However, the addition of molecular imprinting detection further enabled a more accurate and definitive preoperative evaluation especially for morphologically indeterminate thyroid nodules and cases with potentially discordant results among standard modalities.
- 1 April 2024
- Published by AME Publishing Company in Chinese Clinical Oncology
- Vol. 13 (2) , 21
Open AccessStepwise analysis of thyroid diagnostic modalities with genomic imprinting detection
Background: The current preoperative malignancy risk evaluation for thyroid nodules involves stepwise diagnostic modalities including ultrasonography, thyroid function serology and fine-needle aspiration (FNA) cytopathology, respectively. We aimed to substantiate the stepwise contributions of each diagnostic step and additionally investigate the diagnostic significance of quantitative chromogenic imprinted gene in-situ hybridization (QCIGISH)—an adjunctive molecular test based on epigenetic imprinting alterations. Methods: A total of 114 cytopathologically-diagnosed and histopathologically-confirmed thyroid nodules with complete ultrasonographic and serological examination records were evaluated using QCIGISH in the study. Logistic regression models for thyroid malignancy prediction were developed with the stepwise addition of each diagnostic modality and the contribution of each step evaluated in terms of discrimination performance and goodness-of-fit. Results: From the baseline model using ultrasonography [area under the receiver operating characteristics curve (AUROC): 0.79; 95% confidence interval (CI): 0.71–0.86], significant improvements in thyroid malignancy discrimination were observed with the stepwise addition of thyroid function serology (AUROC: 0.82; 95% CI: 0.74–0.90; P=0.23) and FNA cytopathology (AUROC: 0.88; 95% CI: 0.81–0.94; P=0.02), respectively. The inclusion of QCIGISH as an adjunctive molecular test further advanced the preceding model’s diagnostic performance (AUROC: 0.95; 95% CI: 0.91–1.00, P=0.007). Conclusions: Our study demonstrated the significant stepwise diagnostic contributions of standard clinical assessments in the malignancy risk stratification of thyroid nodules. However, the addition of molecular imprinting detection further enabled a more accurate and definitive preoperative evaluation especially for morphologically indeterminate thyroid nodules and cases with potentially discordant results among standard modalities.
- Open Access
- 30 January 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1309005
A comparative analysis of core needle biopsy and repeat fine needle aspiration in patients with inconclusive initial cytology of thyroid nodules
Purpose: To assess and compare the effectiveness of ultrasound-guided core needle biopsy (CNB) in comparison to repeat fine-needle aspiration(rFNA) for thyroid nodules that yield inconclusive results following the initial fine-needle aspiration (FNA).Methods: A cohort of 471 patients who received an inconclusive cytological diagnosis following the initial FNA were included in this study. These patients subsequently underwent either CNB (n=242) or rFNA (n=229). The inconclusive FNA results encompassed categories I, III, and IV of The Bethesda System for Reporting Thyroid Cytopathology(TBSRTC), as well as the ultrasound images indicating malignancy despite FNA results falling under TBSRTC category II. This study assessed the sampling satisfaction rate, diagnostic efficacy, and complications associated with CNB compared to rFNA. Additionally, the impact of repeat puncture time and nodule size on diagnostic efficacy was analyzed.Results: Following repeat punctures, the satisfaction rate of the CNB sampling was found to be significantly higher than that of rFNA (83.9% vs 66.8%). The diagnostic rate in the CNB group was significantly greater compared to that of the rFNA group (70.7% vs 35.8%). In patients with nodule maximum diameters ranging from 5 mm to 20 mm, the diagnostic accuracy was significantly higher in the CNB group compared to that in the rFNA group. In patients with intervals less than 90 days, between 90 days and one year, the diagnostic rate in the CNB group was found to be higher compared to that in the rFNA group. In CNB, not immediately adjacent to the capsule was a risk factor for nodular puncture bleeding (37.0% vs 22.7%.)Conclusion: CNB demonstrated higher rates of satisfaction and diagnosis compared to the rFNA. The diagnostic effectiveness of CNB was not influenced by the time interval or the size of the thyroid nodule. Therefore, in cases where the initial FNA diagnosis of thyroid nodules is inconclusive, CNB should be considered as a viable option for re-puncture.
- 30 January 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1309005
Open AccessA comparative analysis of core needle biopsy and repeat fine needle aspiration in patients with inconclusive initial cytology of thyroid nodules
Purpose: To assess and compare the effectiveness of ultrasound-guided core needle biopsy (CNB) in comparison to repeat fine-needle aspiration(rFNA) for thyroid nodules that yield inconclusive results following the initial fine-needle aspiration (FNA).Methods: A cohort of 471 patients who received an inconclusive cytological diagnosis following the initial FNA were included in this study. These patients subsequently underwent either CNB (n=242) or rFNA (n=229). The inconclusive FNA results encompassed categories I, III, and IV of The Bethesda System for Reporting Thyroid Cytopathology(TBSRTC), as well as the ultrasound images indicating malignancy despite FNA results falling under TBSRTC category II. This study assessed the sampling satisfaction rate, diagnostic efficacy, and complications associated with CNB compared to rFNA. Additionally, the impact of repeat puncture time and nodule size on diagnostic efficacy was analyzed.Results: Following repeat punctures, the satisfaction rate of the CNB sampling was found to be significantly higher than that of rFNA (83.9% vs 66.8%). The diagnostic rate in the CNB group was significantly greater compared to that of the rFNA group (70.7% vs 35.8%). In patients with nodule maximum diameters ranging from 5 mm to 20 mm, the diagnostic accuracy was significantly higher in the CNB group compared to that in the rFNA group. In patients with intervals less than 90 days, between 90 days and one year, the diagnostic rate in the CNB group was found to be higher compared to that in the rFNA group. In CNB, not immediately adjacent to the capsule was a risk factor for nodular puncture bleeding (37.0% vs 22.7%.)Conclusion: CNB demonstrated higher rates of satisfaction and diagnosis compared to the rFNA. The diagnostic effectiveness of CNB was not influenced by the time interval or the size of the thyroid nodule. Therefore, in cases where the initial FNA diagnosis of thyroid nodules is inconclusive, CNB should be considered as a viable option for re-puncture.